Khaishgi Mohammedulla, a director at IBEX Ltd (NASDAQ:IBEX), recently sold 465 common shares of the company, according to a filing with the Securities and Exchange Commission. The shares were sold at an average price of approximately $20.00, resulting in a total transaction value of around $9,300. Following this sale, Mohammedulla retains ownership of 223,687 shares in the company. The transaction was executed in multiple trades with prices ranging from $20.00 to $20.03.
In other recent news, IBEX Limited has reported significant developments. The company kicked off fiscal year 2025 with a record Q1 revenue of $129.7 million, a 4.1% increase year-over-year. Adjusted EBITDA also saw growth, rising to $15.6 million, and adjusted EPS experienced a 30% surge to $0.52. These achievements have led the firm to raise its full-year revenue guidance to a range of $515 million to $525 million.
While the company has seen a slight decline in net cash from operating activities and an increase in Days Sales Outstanding, management remains optimistic about the future. Growth in market share, particularly among top clients, and expansion into new business lines and geographies are expected to drive continued success. Despite a 13% decrease in FinTech sector revenue, IBEX Limited has demonstrated strong performance in HealthTech, retail and e-commerce, and travel transportation and logistics sectors.
The recent launch of three new client relationships and the receipt of the 2024 Generative AI Product of the Year Award for AI Translate further underscore the company's progress. As these recent developments unfold, IBEX Limited continues to focus on maintaining revenue growth and enhancing profitability.
InvestingPro Insights
While director Khaishgi Mohammedulla's recent sale of IBEX Ltd (NASDAQ:IBEX) shares might raise eyebrows, a closer look at the company's financials and market performance reveals a more nuanced picture. According to InvestingPro data, IBEX is currently trading at a P/E ratio of 9.88, which is considered low relative to its near-term earnings growth. This valuation metric suggests that the stock may be undervalued, potentially offering an attractive entry point for investors.
Moreover, IBEX has demonstrated strong market performance, with a 31.38% price total return over the past six months. This robust growth is complemented by the company's solid financial health. An InvestingPro Tip highlights that IBEX operates with a moderate level of debt, and its cash flows can sufficiently cover interest payments. This financial stability may provide reassurance to investors concerned about the director's share sale.
It's worth noting that IBEX has a market capitalization of $325.07 million and has been profitable over the last twelve months, with a basic EPS from continuing operations of $1.95. These figures, combined with analysts' predictions of profitability for the current year, paint a picture of a company with solid fundamentals.
For investors seeking more comprehensive insights, InvestingPro offers 11 additional tips for IBEX, providing a deeper understanding of the company's financial position and market outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.